Evaluation of Colorectal Cancers in Terms of Diagnosis and Treatment Processes
PDF
Cite
Share
Request
Research Article
VOLUME: 31 ISSUE: 3
P: 239 - 245
September 2021

Evaluation of Colorectal Cancers in Terms of Diagnosis and Treatment Processes

Turk J Colorectal Dis 2021;31(3):239-245
1. Kafkas University Faculty of Medicine, Department of General Surgery, Kars, Turkey
2. Kafkas University Faculty of Medicine, Department of Radiology, Kars, Turkey
3. Kafkas University Faculty of Medicine, Department of Patology, Kars, Turkey
No information available.
No information available
Received Date: 20.01.2021
Accepted Date: 14.02.2021
Publish Date: 14.09.2021
PDF
Cite
Share
Request

ABSTRACT

Aim:

In this study, it was aimed to compare the results of preoperative clinical staging with pathological staging determined in postoperative resection material in colorectal cancers.

Method:

The medical data of 86 patients who were operated for colorectal tumor between January 2013 and October 2020 were retrospectively evaluated. Demographic characteristics of the patients, American Society of Anesthesiology score, presence of comorbidity, tumor location, whether preoperative endoscopy was performed, emergency or elective operation, open or laparoscopic surgery, type of surgery, presence of ostomy, morbidity and mortality, pathological diagnosis, radiological and pathological staging informations were recorded and analyzed.

Results:

The most common comorbidity in the study was hypertension, and most of the tumors (36.0%) were located in the sigmoid region. Elective surgery was performed in 66.3% of the patients, resection and primary anastomosis were performed in 76.8% of the patients. Ostomy was created in 85% of the patients over the age of 65. In 82.5 of the patients, the pathological diagnosis was non-mucinous low-grade adenocarcinoma, however, according to the pathological and radiological tumor stage at diagnosis staging, 9 out of every 10 patients were in Stage 2 and Stage 3.

Conclusion:

Radiological staging in the preoperative period is compatible with the pathological staging in the postoperative period.

Keywords:
Colon, colorectal cancer, surgery, tumor stage, pathological staging, laparoscopy

Introduction

Colorectal cancers (CRCs) are among the most common tumors in the gastrointestinal tract and are common in Turkey as well as in the rest of the world. In Turkey, it is the most common type of cancer in women and the fourth most common in men.1

The majority of CRCs are distally located, and the incidence is higher in men.2,3 Anamnesis, physical examination (rectal examination), radiology and endoscopic evaluation (such as localization, passage) are important in the diagnosis process and clinical staging of the disease. Tumor stage at diagnosis (TNM) is one of the most important prognostic factors in CRC.3,4,5 Regional lymph node metastasis is one of the most important parameters in determining treatment and prognosis in CRC. Presence of involvement of lymph nodes affects CRC staging, scope of operation and choice of postoperative oncological treatment. Computed tomography of the abdomen is frequently used in the diagnosis and radiological staging of CRC, and it is seen that computed tomography has a sensitivity of 13-92%, especially in liver metastasis.5,6 Presence of comorbidity, whether the operation is urgent or elective, tumor localization, and preoperatively detected tumor stage may affect treatment methods and postoperative follow-up period.2,3,4,5,6

In our study, it was aimed to compare the radiological staging in the preoperative period with the pathological staging in the resection specimen in CRC.

Materials and Methods

Medical data of 86 patients who were diagnosed as having CRC and operated between January 2013 and October 2020 were evaluated retrospectively. Demographic characteristics of the patients, ASA score, comorbidity, tumor localization, whether or not endoscopy was performed, whether the operation was performed emergency or elective, whether the operation was open or laparoscopic, operation type, presence of ostomy, complication status, postoperative pathological diagnosis, preoperative radiological staging and postoperative pathological staging were recorded. and examined.

Computed tomography images were available in all patients included in the study, and radiological evaluation was obtained with tomography images. In all patients included in the study, oral + IV Dynamic-triphasic sections were obtained by giving contrast material and examination was performed in axial, coronal and sagittal planes.

Ethics committee approval was obtained for the study with the date 24.12.2020 and number 286.

Statistical Analysis

The SPSS version 20 for Windows software package program was used for statistical analysis. Frequencies and percentages were used for descriptive statistics. Chi-square test (Yates correction) was performed in binary comparisons. P value <0.05 was accepted as statistically significant.

Results

In the study, the mean age of our patients who were operated for colorectal tumor was 61.7 (±13.5). Of the patients 53.7% were female and 46.3% were male.

Comorbidity was present in 51.2% of the patients, and ASA2 score was found in 51.2%. It was observed that endoscopic examination was performed in 66.3% of the patients in the preoperative period. During the treatment process, 33.7% of the patients were operated under emergency conditions. Open approach was used in 88.4% of the patients as the surgical method. The rate of ostomy opening was 23.3%. Postoperative complications occurred in 4.7% of patients (anastomotic leakage in two patients, evisceration in one patient, and ureteral injury in one patient). Mortality developed in two patients due to pneumonia and sepsis (Table 1).

When evaluated in terms of age, there was a statistically significant difference between patients with ASA2 and patients with ASA3 (p=0.001), between patients with comorbidity and without comorbidity (p=0.001), and between patients with ostomy and without ostomy (p=0.001). There was no statistically significant difference between patients in whom endoscopy was performed and in whom not performed (p=0.358), between patients who underwent elective surgery and who underwent emergency surgery (p=0.251), between patients who underwent open surgery and who underwent closed surgery (p=0.814), and between patients with complication and without complication (p=0.886) (Table 1).

When evaluated in terms of gender, there was no difference between patients with ASA2 and patients with ASA3 (p=0.679), between patients with comorbidity and without comorbidity (p=0.679), patients in whom endoscopy was performed and in whom not performed (p=0.765), between patients who underwent elective surgery and who underwent emergency surgery (p=0.598), between patients who underwent open surgery and who underwent closed surgery (p=0.300), between patients with ostomy and without ostomy (p=0.289), and between patients with complication and without complication (p=0.402) (Table 1).

The most common comorbidity in our patients was hypertension (15.7%). Type 2 diabetes mellitus was observed in 9.3% of the patients, and the coexistence of hypertension and type 2 diabetes mellitus was observed in 7.0% of the patients (Table 2).

The most common tumor localization was in the left colon and among which the most common was in the sigmoid colon (36%). Of the tumors 12.8% were in the splenic flexure, 10.5% in the rectosigmoid junction, and 10.5% in the rectum (Table 3).

When evaluated in terms of surgery types, 25.6% of the patients underwent anterior resection (AR), 24.4% right hemicolectomy, 20.9% low AR (LAR), and 17.4% Hartmann process (Table 4).

After examining the postoperative resection materials, 82.5% of them were found to be low-differentiated non-mucinous adenocarcinoma, 7.0% moderately differentiated non-mucinous adenocarcinoma, and 10.5% mucinous adenocarcinoma (Table 5).

In terms of pathological staging, 47.7% of the patients were determined as Stage 3, 40.7% as Stage 2, 8.1% as Stage 1, and 3.5% as Stage 4. When evaluated radiologically, 47.7% of the patients were determined as Stage 3, 39.5% as Stage 2, 10.5% as Stage 1, and 2.3% as Stage 4. On the other hand, when pathological staging and radiological staging were compared in terms of TNM staging, the similarity was found to be 94.2% (Table 5).

Discussion

Although the incidence and mortality of CRC vary around the world, its incidence is increasing in relation to obesity, low-fiber and high-fat diet, prolongation of life expectancy, and environmental factors. CRCs are ranked 2nd in cancer-related deaths worldwide (1).

One of the important risk factors for the development of CRC is age. It has been shown that 90% of CRCs occur at the age of 50 years or above. In large case series, it was found that CRC peaked around the age of 70.7,8 In our study, the mean age of patients with CRC was found to be 61.7 (±13.5), which was similar to many other studies.9,10,11,12

The majority of the patients in our study were women. Studies have not shown a significant difference between the frequency of CRC and gender, and it has been shown that the risk increases slightly in men as age progresses.13,14 However, contrary to our study, there are also studies showing that it is more common in males.15,16

Comorbidity was present in 51.2% of the patients in our study, and hypertension was the most common comorbidity. However, 48.8% of the patients were scored as ASA 3 in terms of ASA score. In our study, patients who died had an ASA score of 3 and they had comorbidity. The presence of comorbidities and a high ASA score have been shown to increase morbidity and mortality as an independent risk factor.17,18

Considering the distribution of tumor localization; it was observed that 36% of the tumors were located in the sigmoid region, 21% in the rectum and rectosigmoid, 12.8% in the splenic flexure, and 11.6% in the cecum. In studies, CRC is most commonly detected in the rectosigmoid region, followed by the left and right colon, respectively.16,19 However, it has been observed that the incidence of tumors located in the proximal colon has increased in recent years.19,20

Colonoscopic examination is important in diagnosis of CRC and therapeutic procedures. In our study, endoscopy was performed in 66.3% of all patients and in all elective patients. Preoperative radiological imaging methods are also important because there is a direct relationship between the prognosis and stage of the disease. All patients in the study underwent imaging with computed tomography in the preoperative period and staging was done according to the preoperative TNM staging protocol. As in other gastrointestinal tumors, lymph node detection and staging of the disease by imaging methods are guiding in the treatment of CRCs.21,22

Of the surgeries 66.3% were elective and 33.78% were emergency. CRCs constitute an important part of emergency interventions related to the colon. Although debates continue about the fact that laparoscopic resections have better results than open procedures, they are being performed with increasing frequency.23,24 Laparoscopic resection rates in CRC range from 27.7 to 51.1%.25 In our study, 11.6% of the patients underwent surgery with laparoscopic method, and we attributed the high number of open surgeries to the high number of patients who were operated on urgently.

The treatment method differs according to the localization of the tumor. In many studies, the general approach in tumors located in the right colon is resection and primary anastomosis.26,27 In our study, right hemicolectomy and primary anastomosis were most frequently performed in patients with right colon tumor.26,27 In obstructive left colon tumors, since resection and primary anastomosis in a heavily dilated and dirty colon are considered to be highly risky in terms of anastomotic leakage, stepwise surgical treatment is recommended.28,29 However, in most studies, it has been stated that resection and primary anastomosis can be performed in emergency left colon surgery if the surgery is performed by experienced surgeons with appropriate indications, and similar results in terms of postoperative mortality and complications are encountered among patients undergoing primary anastomosis with step-by-step surgical treatment.30,31 In our study, mostly resection and primary anastomosis were preferred in patients with left colon tumors.

In our study, ostomy was created in 23.3% of the patients in the form of ileostomy (5.9%) and in the form of colostomy (17.4%). The presence of ostomy was higher in patients aged >80 (p=0.001). This situation was similar to the studies conducted.27,8,29,30 In another study, 27.9% of the patients had ostomy in the form of ileostomy or colostomy.32

In our study, our complication rate was 4.7% and our mortality rate was 2.3%, which were acceptable when compared to the literature data. In our study, complications were anastomotic leakage in two of the 4 patients, evisceration in one and ureteral injury in one. Although anastomotic leakage is the most common complication after surgical treatment of CRC, especially due to cancer-specific immune system dysfunction and fecal transmission, many complications such as paralytic ileus, evisceration and surgical site infections may occur. In studies, morbidity and mortality rates were determined as 15-50% and 6-15%, respectively in patients who underwent emergency surgery. Morbidity and mortality rates were found 4-14% and 1-7%, respectively in patients who underwent elective surgery.33,34,35,36 In studies, the postoperative morbidity rate may be up to 23% after laparoscopy and 11-20% after open surgery.37 However, it was reported that anastomotic leakage was seen at a rate of 2.4-6.8% after open surgery and 2.7% after laparoscopy.38

Histological grades of tumors are important in the evaluation of tumor behavior, prognosis and treatment. Tumor stage and histological grade are prognostic factors affecting survival.39,40,41 When the patients were evaluated in terms of pathological diagnosis in the study, 82.5% of the patients had histopathologically low grade non-mucinous adenocarcinoma. In a study by Kocakuşak et al.42, it was histopathologically in the form of non-mucinous adenocarcinoma with a rate of 78%.

Study Limitations

In studies, when stages are evaluated in patients with CRC, it has been reported that Stage 3 is the most common.25,43 In our study, the majority of patients had Stage 2 and 3 in terms of radiological and pathological staging. Similar to our study, in two studies conducted by Sarı et al.44 and Küçüköner et al.45, the most common stage was 2 and 3. Similar to studies, we think that the reason for the diagnosis of CRC in advanced stages is the lack of screening for colon cancer in our country.

Conclusion

In conclusion, tumors located in the left colon in Stage 2-3 were more common in our study. It was observed that the staging performed with preoperative radiological imaging during the diagnosis process was consistent with the staging determined after the pathological examination of the resection piece. In this case, it can be said that the staging is highly compatible in terms of both pathological and radiological diagnosis and the diagnostic processes are of high quality. It is thought that radiological staging is important in treatment planning in patients with CRC, and the success of treatment will increase with developing imaging studies.

Ethics

Ethics Committee Approval: Ethics committee approval was obtained for the study with the date 24.12.2020 and number 286.
Peer-review: Externally peer reviewed.

Authorship Contributions

Surgical and Medical Practices: H.Ç., T.A., T.Ç., H.E.Ö., B.S., K.B., T.A., D.G., Concept: H.Ç., K.B., Design: H.Ç., H.E.Ö., Data Collection or Processing: H.Ç., T.A., Analysis or Interpretation: H.Ç., T.A., D.G., Literature Search: H.Ç., Writing: H.Ç.
Conflict of Interest: No conflict of interest was declared by the authors.
Financial Disclosure: The authors declared that this study received no financial support.

References

1
Gültekin M, Boztaş G, Sağlık Bakanlığı, Türkiye Halk Sağlığı Ku¬rumu, Türkiye kanser istatistikleri, 2014. Available from: https://hsgm.saglik.gov.tr/tr/kanser-istatistikleri
2
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
3
Anuk T, Yıldırım A. Clinical value of platelet-to-lymphocyte ratio in predicting liver metastasis and lymph node positivity of colorectal cancer patients. Turk J Colorectal Dis 2017;27:50-55.
4
Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG Pet, and/or FDG Pet/Ct: a meta-analysis of prospective studies including patients who have not previously under göne treatment. Radiology 2010;257:674-684.
5
Dighe S, Blake H, Koh MD, Swift I, Arnaout A, Temple L. Accuracy of multi detector computed tomography in identifying poor prog¬nostic factors in colonic cancer. Br J Surg 2010;97:1407-1415.
6
Chamadol N, Ninpiethoon T, Bhudhisawasd V, Pairojkul C. The role of CT scan in preoperative staging of colorectal carcinoma. J Med Assoc Thai 2005;88:1847-1853.
7
Esteva M, Ruiz A, Ramos M, Casamitjana M, Sánchez-Calavera MA, González-Luján L, Pita-Fernández S, Leiva A, Pértega-Díaz S, Costa-Alcaraz AM, Macià F, Espí A, Segura JM, Lafita S, Novella MT, Yus C, Oliván B, Cabeza E, Seoane-Pillado T, López-Calviño B, Llobera J; DECCIRE GROUP. Age differences in presentation, diagnosis pathway and management of colorectal cancer. Cancer Epidemiol 2014;38:346-353.
8
Haggar FA, Boushey RP. Colorectal cancer epidemiology: Incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 2009;22:191-197.
9
Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, Wingo PA, Jemal A, Feigal EG. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S cancer burden. Cancer 2002; 94:2766-2792.
10
Wydra J, Kruszewski W, Jasicski W, Szajewski M, Ciesielski M, Szefel J, Walczak J. Is age a risk factor of postoperative complications in colorectal cancer? Pol Przegl Chir 2013;85:491-495.
11
Menteş B, Ege B, Uner A, Unsal D, Yuksel O, Bostancı H, Oguz M. Kolorektal kanserlerin tedavi sonucları: Tek merkezli, 200 vakalık seri. Gazi Med J 2007;18:97-103.
12
Ozkan OF, Kaya U, Guner A, Cevizci S, Ozkul F, Sezer C, Reis E. Kolorektal kanser hastalarının demografik dağılımı ve hastalık ozellikleri. Pam Tıp Derg 2012;5:132-135.
13
Boyle P, Leon ME. Epidemiology of colorectal cancer. Br Med Bull 2002;64:1-25.
14
Steven K. Libutti, Leonard B. Saltz, Christopher G. Willett. Cancer of the Colon. In: Devita VT, Lawrence T, Rosenberg SA, eds. Cancer: Principles and Practise of Oncology. 9th ed. Philadelphia: Lippincott Williams &Wilkins. 2011:1074-1127.
15
Gürsoy Ş, Er Ö, Canöz Ö, Güven M, Başkol M, Güven K, Özbakır Ö, Yücesoy M. Kayseri ve yöresinde kolon kanserlerinin özellikleri. Akademik Gastroenteroloji Dergisi 2003;2:60-63.
16
Bayar B, Yılmaz K, Akıncı M, Şahin A, Kulaçoğlu H. An evaluation of treatment results of emergency versus elective surgery in colorectal cancer patients. Ulus Cerrahi Derg 2016;32:11-17.
17
Klima DA, Brintzenhoff RA, Agee N, Walters A, Heniford BT, Mostafa G. A review of factors that affect mortality following colectomy. J Surg Res 2012;174:192-199.
18
Ihedioha U, Gravante G, Lloyd G, Sangal S, Sorge R, Singh B, Chaudhri S . Curative colorectal resections in patients aged 80 years and older: Clinical characteristics, morbidity, mortality and risk factors. Int J Colorectal Dis 2013;28:941-947.
19
Li M, Gu J. Changing patterns of colorectal cancer in China over a period of 20 years. World J Gastroenterol 2005;11:4685-4688.
20
Rozen P, Liphshitz I, Barchana M. The changing epidemiology of colorectal cancer and its relevance for adapting screening guidelines and methods. Eur J Cancer Prev 2011;20:46-53.
21
O’Connell MJ, Colangelo LH, Beart RW, Petrelli NJ, Allegra CJ, Sharif S, Pitot HC, Shields AF, Landry JC, Ryan DP, Parda DS, Mohiuddin M, Arora A, Evans LS, Bahary N, Soori GS, Eakle J, Robertson JM, Moore DF Jr, Mullane MR, Marchello BT, Ward PJ, Wozniak TF, Roh MS, Yothers G, Wolmark N.Capecitabine and oxaliplatin in the preoperative multi modality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04. J Clin Oncol 2014;32:1927-1934.
22
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20.
23
Rea JD, Cone MM, Diggs BS, Deveney KE, Lu KC, Herzig DO. Utilization of laparoscopiccolectomy in the United Statesbeforeandaftertheclinicaloutcomes of surgicaltherapystudygrouptrial. Ann Surg 2011;254:281-288
24
McKay GD, Morgan MJ, Wong SK, Gatenby AH, Fulham SB, Ahmed KW, Toh JW, Hanna M, Hitos K; South Western Sydney Colorectal Tumor Group. Improved short-term outcomes of laparoscopic versus open resection for colon and rectal cancer in an area health service: a multi center study. Dis Colon Rectum 2012;55:42-50.
25
Pecorelli N, Amodeo S, Frasson M, Vignali A, Zuliani W, Braga M. Ten-year outcomes following laparoscopic colorectal resection: results of a randomized controlled trial. Int J Colorectal Dis 2016; 31:1283-1290. 
26
Zorcolo L, Covotta L, Carlomagno N, Bartolo DC. Safety of primary anastomosis in emergency colo-rectal surgery. Colorectal Dis 2003;5:262-269.
27
Smothers L, Hynan L, Fleming J, Turnage R, Simmang C, Anthony T. Emergency surgery for colon carcinoma. Dis Colon Rectum 2003;46:24-30.
28
Ansaloni L, Andersson RE, Bazzoli F, Catena F, Cennamo V, Di Saverio S, Fuccio L, Jeekel H, Leppäniemi A, Moore E, Pinna AD, Pisano M, Repici A, Sugarbaker PH, Tuech JJ. Guidelines in the management of obstructing cancer of the left colon: consensus conference of the world society of emergency surgery (WSES) and peritoneum and surgery (PnS) society. World J Emerg Surg 2010;5:29.
29
Oren D, Ozturk G. Kolorektal kanserlerde guncel acil tedavi. Turkiye Klinikleri J Gen Surg-Special Topics 2009;2:127-133.
30
Jimenez Fuertes M, Costa Navarro D. Resection and primary anastomosis without diverting ileostomy for left colon emergencies: is it a safe procedure? World J Surg 2012;36:1148-1153.
31
Seah DW, Ibrahim S, Tay KH. Hartmann procedure: is it still relevant today? ANZ J Surg 2005;75:436-440.
32
Aydın OU, Soylu L. Predictive factors for the development of surgical site ınfection after colorectal cancer surgery. Turk J Colorectal Dis 2018;28:61-68.
33
Barrier A, Ferro L, Houry S, Lacaine F, Huguier M. Rectal cancer surgery in patients more than 80 years of age. Am J Surg 2003;185:54-57.
34
Gurlich R, Maruna P, Kalvach Z, Peskova M, Cermak J, Frasko R. Colon resection in elderly patients: comparison of data of a single surgical department with collective data from the Czech Republic. Arch Gerontol Geriatr 2005;41:183-190.
35
Tekkis PP, Kinsman R, Thompson MR, Stamatakis JD. The Association of Coloproctology of Great Britain and Ireland study of large bowel obstruction caused by colorectal cancer. Ann Surg 2004;204:76-81.
36
Sjo OH, Larsen S, Lunde OC, Nesbakken A. Short term outcome after emergency and elective surgery for colon cancer. Colorectal Dis 2009;11:733-739.
37
Veldkamp R, Kuhry E, Hop WC Jeekel J, Kazemier G, Bonjer HJ, Haglind E, Påhlman L, Cuesta MA, Msika S, Morino M, Lacy AM; Colon cancer Laparoscopic or Open Resection Study Group (COLOR). Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomisedtrial.  Lancet Oncol 2005;6:477-484.
38
Reinke CE, Showalter S, Mahmoud NN, Kelz RR. Comparison of anastomotic leak rate after colorectal surgery using different databases. Dis Colon Rectum 2013; 56:638-644.
39
Makela J, Kiviniemi H, Laitinen S. Prognostic factors after surgery in patients younger than 50 years old with colorectal adenocarcinoma. Hepatogastroenterology 2002;49:971-975.
40
Choi AH, Nelson RA, Schoellhammer HF, Cho W, Ko M, Arrington A, Oxner CR, Fakih M, Wong J, Sentovich SM, Garcia-Aguilar J, Kim J. Accuracy of computed tomography in nodal staging of co¬lon cancer patients. World J Gastrointest Surg 2015;7:116-122.
41
Chi Y, Zhang X, Li J, Sun Y. To be or not to be: significance of lymph nodes on pretreatment CT in predicting survival of rectal cancer patients, Eur J Radiol 2011;777:473-477.
42
Kocakuşak A, Yaşar M, Güler N, Görmüş C, Aydın S, Ozer E, Benek S, Pamak S. Retrospective evaluation of patients aged 45 years or younger diagnosed with colorectal cancer. The Medical Bulletin of Haseki 2011;49:110-113.
43
Erdoğdu UE, Çaycı HM. The effect of resection methods on outcomes in colorectal cancers: does conversion matter? Turk J Colorectal Dis 2017; 27:134-141.
44
Sarı R, Durak D, Yazıcıoğlu M, Gürer A. The role of computed tomography for the detection of lymph node in colon cancers. Bozok Med J 2019; 9:48-51.
45
Küçüköner M, Kaplan M, İnal A, Urakçı Z, Nas N, Işıkdoğan A. Colorectal cancers: 12 year-results of a single center. J Clin Exp Invest 2013;4:208-212.